Taysha Gene Therapies, Inc.
Total Trades
33
Buys
12
Sells
17
Largest Trade
N/A
Insiders
8
Institutional Funds
143
Inst. Value
$1M+
Activist Filings
35
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Alam Kamran | CHIEF FINANCIAL OF… | SELL | $1K–$15K | 2K | $4.52 | Feb 6, 2026 |
| Nagendran Sukumar | President and Head… | SELL | $500K+ | 116K | $4.72 | Jan 27, 2026 |
| Nolan Sean P. | CEO | SELL | $500K+ | 178K | $4.72 | Jan 27, 2026 |
| Alam Kamran | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 103K | $4.72 | Jan 27, 2026 |
| Nagendran Sukumar | President and Head… | SELL | $500K+ | 200K | $4.71 | Jan 14, 2026 |
| Nagendran Sukumar | President and Head… | GRANT | N/A | 427K | — | Jan 14, 2026 |
| Nagendran Sukumar | President and Head… | EXERCISE | $100K–$500K | 200K | $1.15 | Jan 14, 2026 |
| Nagendran Sukumar | President and Head… | SELL | $1M+ | 370K | $4.58 | Dec 2, 2025 |
| Nagendran Sukumar | President and Head… | EXERCISE | $500K+ | 370K | $1.52 | Dec 2, 2025 |
| Nagendran Sukumar | President and Head… | SELL | $500K+ | 200K | $3.23 | Sep 12, 2025 |
| Nagendran Sukumar | President and Head… | EXERCISE | $15K–$50K | 41K | $0.70 | Sep 12, 2025 |
| Nagendran Sukumar | President and Head… | SELL | $100K–$500K | 57K | $2.85 | Aug 22, 2025 |
| Alam Kamran | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 54K | $2.85 | Aug 22, 2025 |
| Manning Paul B | 10% Owner | BUY | $1M+ | 750K | $2.75 | Jun 4, 2025 |
| Manning Paul B | 10% Owner | BUY | $1M+ | 1.3M | $2.25 | Jul 1, 2024 |
| Manning Paul B | 10% Owner | BUY | $100K–$500K | 100K | $1.63 | Nov 20, 2023 |
| Alam Kamran | CFO | SELL | $50K–$100K | 33K | $2.33 | Aug 25, 2023 |
| Manning Paul B | 10% Owner | BUY | $1M+ | 16.5M | $0.90 | Aug 17, 2023 |
| Stalfort John A III | Director | BUY | $500K+ | 778K | $0.90 | Aug 17, 2023 |
| Nolan Sean P. | CEO | BUY | $100K–$500K | 444K | $0.90 | Aug 17, 2023 |
| Donenberg Phillip B. | Director | BUY | $50K–$100K | 111K | $0.90 | Aug 17, 2023 |
| Session R.A. II | 10% Owner | SELL | $50K–$100K | 86K | $0.71 | Jul 14, 2023 |
| Session R.A. II | 10% Owner | SELL | $15K–$50K | 29K | $0.70 | Jun 26, 2023 |
| Session R.A. II | 10% Owner | SELL | $100K–$500K | 435K | $0.71 | Jun 22, 2023 |
| Nagendran Sukumar | President and Head… | BUY | $1K–$15K | 5K | $0.68 | May 18, 2023 |
| Manning Paul B | Director | BUY | $1M+ | 1.5M | $2.00 | Nov 2, 2022 |
| Alam Kamran | CFO | SELL | $1K–$15K | 3K | $3.47 | Aug 24, 2022 |
| Alam Kamran | CFO | SELL | $100K–$500K | 29K | $3.70 | Aug 23, 2022 |
| PRASAD SUYASH | CMO and Head of R&D | SELL | $15K–$50K | 13K | $3.71 | Jul 7, 2022 |
| PRASAD SUYASH | CMO and Head of R&D | SELL | $100K–$500K | 50K | $3.65 | Jul 1, 2022 |
| Manning Paul B | Director | BUY | $1M+ | 202K | $7.80 | Feb 4, 2022 |
| Nagendran Sukumar | Director | BUY | $50K–$100K | 10K | $8.01 | Feb 3, 2022 |
| Donenberg Phillip B. | Director | BUY | $15K–$50K | 3K | $7.78 | Feb 3, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 143 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 23.6M | $1M+ | SH |
| VANGUARD GROUP INC | 11.5M | $1M+ | SH |
| STATE STREET CORP | 10.8M | $1M+ | SH |
| Siren, L.L.C. | 10.1M | $1M+ | SH |
| Octagon Capital Advisors LP | 8.9M | $1M+ | SH |
| BARCLAYS PLC | 5.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 4.7M | $1M+ | SH |
| Point72 Asset Management, L.P. | 3.9M | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 3.7M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 3.3M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 2.5M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 2.5M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9M | $1M+ | SH |
| NORGES BANK | 1.8M | $1M+ | SH |
| Palo Alto Investors LP | 1.2M | $1M+ | SH |
| Aberdeen Group plc | 1.0M | $1M+ | SH |
| Informed Momentum Co LLC | 824K | $1M+ | SH |
| Quantum Private Wealth, LLC | 820K | $1M+ | SH |
| SG Americas Securities, LLC | 781K | $1M+ | SH |
| Sands Capital Alternatives, LLC | 725K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 5, 2026
4.9%
13.5M shares
SC 13G/A · Jan 21, 2026
6.5%
17.9M shares
SC 13G/A · Nov 14, 2025
3.3%
9.1M shares
SC 13G/A · Nov 14, 2025
9.9%
27.7M shares
SC 13G/A · Aug 14, 2025
9.9%
25.3M shares
SC 13G/A · Aug 14, 2025
9.9%
25.2M shares
SC 13G/A · Aug 6, 2025
6.7%
16.9M shares
SC 13G/A · Aug 6, 2025
6.2%
15.6M shares
SC 13G/A · Jul 16, 2025
5.2%
13.2M shares
SC 13G · Jul 3, 2025
5.1%
12.7M shares
SC 13D/A · Jun 4, 2025
9.8%
25.6M shares
SC 13G/A · May 15, 2025
10.0%
20.7M shares
SC 13G/A · Feb 14, 2025
5.9%
12.4M shares
SC 13G/A · Feb 12, 2025
8.0%
16.4M shares
SC 13G · Feb 5, 2025
5.1%
10.4M shares
SC 13G · Feb 5, 2025
8.6%
17.6M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Nov 14, 2024
4.4%
9.0M shares
SC 13G/A · Nov 14, 2024
10.0%
21.5M shares
SC 13G · Nov 14, 2024
10.0%
23.1M shares
SC 13G/A · Nov 12, 2024
9.1%
18.7M shares
SC 13G · Nov 8, 2024
6.6%
13.5M shares
SC 13G · Oct 22, 2024
6.6%
13.5M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 15, 2024
5.6%
10.4M shares
SC 13G/A · Feb 14, 2024
10.0%
18.7M shares
SC 13G · Feb 14, 2024
9.8%
18.5M shares
SC 13G/A · Sep 11, 2023
15.0%
28.0M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Aug 28, 2023
7.7%
14.4M shares
SC 13G · Aug 25, 2023
10.0%
18.7M shares
SC 13G · Aug 25, 2023
5.9%
11.1M shares
SC 13D/A · Aug 21, 2023
12.6%
23.5M shares
SC 13D/A · Aug 18, 2023
3.9%
7.3M shares
SC 13G/A · Nov 10, 2022
6.0%
3.3M shares
SC 13D/A · Nov 2, 2022
11.2%
7.0M shares
SC 13D · Oct 31, 2022
11.6%
7.3M shares
SC 13G · Jul 8, 2022
2.6%
1.0M shares